News
Janssen has announced topline results from the Phase II GALAXI 1 clinical which showed rates of clinical remission previously reported at week 12...
The National Institutes of Health has commenced a long-term investigation into the impacts of COVID-19 in children. The study, supported by the...
New data from AstraZeneca’s COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials have revealed high efficacy from a dose of...
NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults...
UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight common...
Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in 95 low- and middle-income...
The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according...
Orexo announced it has successfully completed the trial for its lead pharmaceutical pipeline asset, OX124, designed to help patients in the fight...
The biotechnology company Moderna have announced positive data from the AstraZeneca-led Phase IIa EPICCURE trial, evaluating the use of a messenger...
Twist Bioscience Corporation announced that it has launched Revelar Biotherapeutics, an independently operated, new biotechnology company to develop...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
